Abstract:Streptococcus suis serotype 2 is an important encapsulated bacterial swine pathogen and zoonotic agent for which no effective vaccine exists. The interaction with B cells and the humoral response against S . suis are poorly understood despite their likely relevance for a potential vaccine. We evaluated germinal center (GC) B cell kinetics, as well as the production and role of S . suis -specific antibodies following infections in a mouse model. We found that mice infected with S . suis developed GC that peaked 13–21 days post-infection. GC further increased and persisted upon periodic reinfection that mimics real life conditions in swine farms. Anti- S . suis IgM and several IgG subclasses were produced, but antibodies against the S . suis capsular polysaccharide (CPS) were largely IgM. Interestingly, depletion of total IgG from the wild-type mice sera had no effect on bacterial killing by opsonophagocytosis in vitro . Somatic hypermutation and isotype switching were dispensable for controlling the infection or anti-CPS IgM production. However, T cell-deficient ( Tcrb-/- ) mice were unable to control bacteremia, produce optimal anti-CPS IgM titers, or elicit antibodies with opsonophagocytic activity. SAP deficiency, which prevents GC formation but not extrafollicular B cell responses, ablated anti S . suis -IgG production but maintained IgM production and eliminated the infection. In contrast, B cell deficient mice were unable to control bacteremia. Collectively, our results indicate that the antibody response plays a large role in immunity against S . suis , with GC-independent but T cell-dependent germline IgM being the major effective antibody specificities. Our results further highlight the importance IgM, and potentially anti-CPS antibodies, in clearing S . suis infections and provide insight for future development of S . suis vaccines. Streptococcus suis is an important bacterial pathogen that affects swine and can cause severe infections in humans. To date, there is no efficacious vaccine commercially available to prevent S . suis infections. To make it worse, little is known on how the bacterium interacts with B cells, which are the cells that produce protective antibodies. In this work, we sought to better understand how antibodies are produced following infection, what is their specific targets and which antibodies play an important role in the elimination of the bacteria. To do so, we first performed infection and immunisation trials in mice to characterize how the antibody response develops. Following this, we tested mice of various genetic profiles to evaluate the role of important genes and cell types in the production of useful antibodies. The results obtained in this study indicate that IgM antibodies, such as the ones able to target the protective shell of the bacteria, play an important role in S . suis elimination. The acquired knowledge in this study provides a better understanding of how the immune response develops against S . suis and brings insight for future development of vaccines against S . suis .

Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells

Flanking N- and C-terminal domains of PrsA in <i>Streptococcus suis</i> type 2 are crucial for inducing cell death independent of TLR2 recognition

Streptococcus suis subtilisin-like serine proteases SspA-1 and SspA-2 interplay with complement C3a and C5a to facilitate bacterial immune evasion and infection

PrsA Contributes to Streptococcus Suis Serotype 2 Pathogenicity by Modulating Secretion of Selected Virulence Factors.

Comparative analysis of the interactions of different Streptococcus suis strains with monocytes, granulocytes and the complement system in porcine blood

Encapsulated Streptococcus suis impairs optimal neutrophil functions which are not rescued by priming with colony-stimulating factors

Roles of the Putative Type IV-like Secretion System Key Component VirD4 and PrsA in Pathogenesis of Streptococcus Suis Type 2.

Insight into the role of Streptococcus suis zinc metalloprotease C from the new serotype causing meningitis in piglets

Regulative synthesis of capsular polysaccharides in the pathogenesis of Streptococcus suis

Unmutated but T cell dependent IgM antibodies targeting Streptococcus suis play an essential role in bacterial clearance

Attenuation of Streptococcus suis virulence by the alteration of bacterial surface architecture

Stk and Stp1 Participate in Streptococcus Suis Serotype 2 Pathogenesis by Regulating Capsule Thickness and Translocation of Certain Virulence Factors.

Construction and Characterization of Streptococcus Suis Type 2 Mutant Strain with Suilysin Gene Deletion

Interleukin-1 signaling induced by Streptococcus suis serotype 2 is strain-dependent and contributes to bacterial clearance and inflammation during systemic disease in a mouse model of infection

O-acetyl-homoserine Sulfhydrylase Deficient Streptococcus Suis Serotype 2 Strain SC19 Becomes an Avirulent Strain and Provides Immune Protection Against Homotype Infection in Mice

Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross protection against serotype 9 strain.

Endopeptidase O promotes Streptococcus suis immune evasion by cleaving the host- defence peptide cathelicidins

AI-2 quorum sensing-induced galactose metabolism activation in Streptococcus suis enhances capsular polysaccharide-associated virulence

HylS', a fragment of truncated hyaluronidase of Streptococcus suis, contributes to immune evasion by interaction with host complement factor C3b

The suppressive role of NLRP6 in host defense against Streptococcus suis infection

Virulence genes, resistome and mobilome of Streptococcus suis strains isolated in France